Skip Nav Destination
Issues
1997
This article was originally published in
Skin Pharmacology
ISSN 1011-0283
EISSN 2571-7162
In this Issue
Journal Name Change
Vol. 1-10 (1988-1997) were published under the journal's former title Skin Pharmacology and Vol. 11-16 (1998-2003) under Skin Pharmacology and Applied Skin Physiology, respectively.
Skin Pharmacology 1997, Vol. 10, No. 2
Original Research Article
Immunological Gene Therapy Approaches for Malignant Melanoma: 1. Tumor-lmmunological Background
Skin Pharmacology (1997) 10 (2): 49–62.
https://doi.org/10.1159/000211469
A Skin Equivalent Model for Cosmetological Trials: An in vitro Efficacy Study of a New Biopeptide
Skin Pharmacology (1997) 10 (2): 63–70.
https://doi.org/10.1159/000211470
Bisindolylmaleimide Protein-Kinase-C Inhibitors Delay the Decline in DNA Synthesis in Mouse Hair Follicle Organ Cultures
Skin Pharmacology (1997) 10 (2): 71–78.
https://doi.org/10.1159/000211471
Cyclosporin G Inhibits Proliferation of A431 Cells in a Dose-and Time-Dependent Manner Comparable to Cyclosporin A
Skin Pharmacology (1997) 10 (2): 79–84.
https://doi.org/10.1159/000211472
Topical Retinol and the Stratum corneum Response to an Environmental Threat
Skin Pharmacology (1997) 10 (2): 85–89.
https://doi.org/10.1159/000211473
The Effect of Tamol on Human Mast Cell Chymase and Plasmin
Skin Pharmacology (1997) 10 (2): 90–96.
https://doi.org/10.1159/000211474
Oxyhemoglobin Is a Quantifiable Measure of Experimentally Induced Chronic Tretinoin Inflammation and Accommodation in Photodamaged Skin
Skin Pharmacology (1997) 10 (2): 97–104.
https://doi.org/10.1159/000211475
